Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $922.16 billion, total revenue of $176.81 billion and a weighted average PE ratio of 47.73.
Market Cap
922.16B
Revenue
176.81B
Profits
19.32B
PE Ratio
47.73
Profit Margin
10.93%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 257.42B | 2.63% | 2,090,807 | 47.35B |
| 2 | DHR | Danaher Corporation | 161.99B | 1.73% | 4,061,120 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 53.26B | 0.79% | 589,101 | 4.66B |
| 4 | A | Agilent Technologies, Inc. | 49.27B | 1.73% | 2,048,563 | 7.37B |
| 5 | NTRA | Natera, Inc. | 45.05B | -14.59% | 5,777,245 | 2.91B |
| 6 | WAT | Waters Corporation | 44.96B | 1.00% | 695,786 | 5.61B |
| 7 | IQV | IQVIA Holdings Inc. | 44.80B | 2.62% | 1,398,400 | 17.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 34.25B | 2.57% | 350,589 | 4.20B |
| 9 | ILMN | Illumina, Inc. | 32.23B | 2.47% | 2,064,518 | 4.54B |
| 10 | LH | Labcorp Holdings Inc. | 29.77B | 0.90% | 610,120 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 28.12B | 0.35% | 945,181 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 20.41B | -1.67% | 5,513,612 | 1.28B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.27B | 2.86% | 231,625 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.31B | 2.84% | 1,683,266 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.17B | 7.83% | 1,063,762 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 15.34B | 1.53% | 1,379,676 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.39B | -1.04% | 3,394,157 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 5.98B | -2.58% | 1,664,323 | 2.27B |
| 19 | GRAL | GRAIL, Inc. | 5.46B | 1.94% | 756,383 | 166.60M |
| 20 | BLLN | BillionToOne, Inc. | 5.38B | 1.38% | 993,251 | 436.87M |
| 21 | SHC | Sotera Health Company | 4.57B | 0.88% | 2,199,215 | 1.23B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.53B | 4.29% | 3,333,526 | 298.01M |
| 23 | CDNA | CareDx, Inc. | 4.13B | 2.92% | 1,126,412 | 497.40M |
| 24 | NEO | NeoGenomics, Inc. | 2.18B | 2.12% | 1,314,124 | 787.75M |
| 25 | VCYT | Veracyte, Inc. | 1.95B | 0.67% | 6,582,305 | 581.78M |
| 26 | WGS | GeneDx Holdings Corp. | 1.86B | -3.09% | 1,204,589 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.71B | 1.54% | 3,000,201 | 80.77M |
| 28 | OPK | OPKO Health, Inc. | 1.28B | -1.14% | 6,903,966 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.09B | -2.77% | 2,457,794 | 35.41M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.00B | -4.91% | 981,764 | 377.13M |
| 31 | FLGT | Fulgent Genetics, Inc. | 663.27M | 27.22% | 1,097,522 | 330.28M |
| 32 | MYGN | Myriad Genetics, Inc. | 567.86M | -5.88% | 2,563,822 | 803.60M |
| 33 | BNR | Burning Rock Biotech Limited | 141.53M | 1.28% | 13,542 | 73.70M |
| 34 | XGN | Exagen Inc. | 140.75M | -23.55% | 1,196,212 | 71.12M |
| 35 | BDSX | Biodesix, Inc. | 90.00M | -57.01% | 1,590,082 | 105.21M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 81.48M | 1.22% | 94,891 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 60.03M | 2.41% | 202,351 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 33.33M | 0.16% | 13,873 | 27.20M |
| 39 | MDXH | MDxHealth SA | 14.98M | 3.97% | 447,303 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.09M | -5.59% | 1,200 | - |
| 41 | XWEL | XWELL, Inc. | 5.05M | 2.78% | 16,990 | 28.28M |
| 42 | BIAF | bioAffinity Technologies, Inc. | 3.48M | 4.42% | 24,832 | 5.53M |
| 43 | ADVB | Advanced Biomed Inc. | 3.27M | 4.21% | 8,650 | 127.64K |
| 44 | ISPC | iSpecimen Inc. | 2.05M | 0.78% | 239,613 | 466.30K |